India's Open Source Drug Discovery Initiative Compiles The TB Genome; Calls For Stronger Global Partnerships For Leads
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - A decade after the mycobacterium tuberculosis genome sequence was deciphered, the Indian government's ambitious Open Source Drug Discovery initiative released what is claimed to be the first-ever comprehensive compilation of the mapped TB genome. The collated data will be made available through an open public portal for further analysis, leads and research collaborations
You may also be interested in...
Janssen Plans Tiered Pricing For Sirturo In India; Will Work With Government Agencies For Right Use
The TB treatment will be brought to India with a tiered-pricing mechanism, but Janssen says it will work with partners to ensure appropriate use in a country with the highest population of MDR-TB patients.
Janssen Plans Tiered Pricing For Sirturo In India; Will Work With Government Agencies For Right Use
The TB treatment will be brought to India with a tiered-pricing mechanism, but Janssen says it will work with partners to ensure appropriate use in a country with the highest population of MDR-TB patients.
Big Pharmas Come Together On TB, But Effort To Accelerate Development May Hit Speedbump From Lack Of Biomarkers
A new multi-pharma company collaboration is intended to dramatically speed development of new combination regimens for tuberculosis, but efforts to accelerate development may be hindered by the lack of biomarkers for TB